Literature DB >> 2504079

Midazolam-alfentanil synergism for anesthetic induction in patients.

H R Vinik1, E L Bradley, I Kissin.   

Abstract

The effect of midazolam on the induction dose-response curve for alfentanil was studied in nonpremedicated ASA physical status I or II patients. The response to the verbal command was used as an end point of anesthesia. Dose-response curves for midazolam, alfentanil, and their combination were determined with a probit procedure, and compared with algebraic (fractional) analysis of drug interaction. Interaction between midazolam and alfentanil was found to be synergistic (supraadditive). The results suggest that the use of this combination is advantageous not only because it helps to achieve different anesthetic goals with specific drugs (a benzodiazepine for unconsciousness and an opioid for blockade of the responses to noxious stimulation), but also because its components are complementary for unconsciousness.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2504079

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  11 in total

1.  Population pharmacodynamic modelling of lorazepam- and midazolam-induced sedation upon long-term continuous infusion in critically ill patients.

Authors:  Eleonora L Swart; Klaas P Zuideveld; Joost de Jongh; Meindert Danhof; Lambertus G Thijs; Robert M J Strack van Schijndel
Journal:  Eur J Clin Pharmacol       Date:  2006-01-20       Impact factor: 2.953

2.  Sedation in the ICU.

Authors:  H R Vinik; I Kissin
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

Review 3.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

Review 4.  Adverse effects of opioid agonists and agonist-antagonists in anaesthesia.

Authors:  T A Bowdle
Journal:  Drug Saf       Date:  1998-09       Impact factor: 5.606

5.  Small bolus injections of intravenous midazolam for upper gastrointestinal endoscopy: a study of 788 consecutive cases.

Authors:  M R Smith; G D Bell; M A Quine; G M Spencer; A E Morden; J G Jones
Journal:  Br J Clin Pharmacol       Date:  1993-12       Impact factor: 4.335

6.  Effect of ketamine pretreatment for anaesthesia in patients undergoing percutaneous transluminal balloon angioplasty with continuous remifentanil infusion.

Authors:  Na Hyung Jun; Jae Kwang Shim; Yong Sun Choi; Seung Ho An; Young Lan Kwak
Journal:  Korean J Anesthesiol       Date:  2011-10-22

7.  Factors affecting prolonged time to extubation in patients given remimazolam.

Authors:  Yoko Shimamoto; Michiyoshi Sanuki; Shigeaki Kurita; Masaya Ueki; Yoshie Kuwahara; Ayumu Matsumoto
Journal:  PLoS One       Date:  2022-05-18       Impact factor: 3.240

8.  Intranasal midazolam for the sedation of geriatric patients with care-resistant behaviour during essential dental treatment: An observational study.

Authors:  Clemens R M Barends; Anthony R Absalom; Anita Visser
Journal:  Gerodontology       Date:  2021-03-21       Impact factor: 2.750

9.  Comparison of sedation between dexmedetomidine and propofol during transesophageal echocardiography: A randomized controlled trial.

Authors:  Azin Alizadehasl; Anita Sadeghpour; Ziae Totonchi; Rasoul Azarfarin; Saeid Rahimi; Amir Hendiani
Journal:  Ann Card Anaesth       Date:  2019 Jul-Sep

10.  Time-to-Event Modeling for Remimazolam for the Indication of Induction and Maintenance of General Anesthesia.

Authors:  Lauren L Lohmer; Frank Schippers; Karl Uwe Petersen; Thomas Stoehr; Virginia D Schmith
Journal:  J Clin Pharmacol       Date:  2020-01-27       Impact factor: 3.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.